Sale!

FXYD2 Gene Hypomagnesemia Type 2 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The FXYD2 Gene Hypomagnesemia Type 2 NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the FXYD2 gene responsible for familial hypomagnesemia type 2. This comprehensive test utilizes next-generation sequencing technology to detect specific genetic variations that disrupt renal magnesium reabsorption, leading to chronic magnesium deficiency. Patients experiencing unexplained muscle cramps, fatigue, cardiac arrhythmias, or neurological symptoms should consider this test for definitive diagnosis. The test provides crucial information for personalized treatment strategies and family planning decisions. Results are available within 3-4 weeks from blood or DNA samples. Priced at $500 USD, this test offers significant savings from the regular $700 USD cost.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

FXYD2 Gene Hypomagnesemia Type 2 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Magnesium Metabolism Disorders

The FXYD2 Gene Hypomagnesemia Type 2 NGS Genetic DNA Test represents a breakthrough in diagnostic precision for individuals suffering from unexplained magnesium deficiency disorders. This advanced genetic test specifically targets mutations in the FXYD2 gene, which encodes the gamma subunit of the Na+/K+-ATPase enzyme complex crucial for renal magnesium handling. By identifying these genetic abnormalities, healthcare providers can establish definitive diagnoses and implement targeted treatment strategies for patients with familial hypomagnesemia type 2.

What This Test Measures and Detects

Our comprehensive NGS genetic test thoroughly analyzes the FXYD2 gene to identify:

  • Point mutations affecting the gamma subunit structure
  • Insertion and deletion variants disrupting protein function
  • Missense mutations altering sodium-potassium pump activity
  • Regulatory region variants affecting gene expression
  • Compound heterozygous mutations in familial cases

The test utilizes state-of-the-art next-generation sequencing technology to provide complete coverage of the FXYD2 gene coding regions, splice sites, and regulatory elements, ensuring maximum detection sensitivity for clinically relevant variants.

Who Should Consider This Genetic Test

This specialized genetic test is recommended for individuals presenting with:

  • Persistent hypomagnesemia unresponsive to standard supplementation
  • Family history of magnesium deficiency disorders
  • Unexplained muscle cramps, spasms, or tetany
  • Cardiac arrhythmias without clear etiology
  • Neurological symptoms including seizures or tremors
  • Chronic fatigue and weakness despite normal electrolyte panels
  • Children with failure to thrive and developmental delays
  • Patients with suspected renal magnesium wasting syndromes

Clinical Benefits of Genetic Testing

Undergoing the FXYD2 Gene Hypomagnesemia Type 2 test provides numerous clinical advantages:

  • Definitive Diagnosis: Confirms genetic basis for magnesium metabolism disorders
  • Personalized Treatment: Enables targeted magnesium supplementation protocols
  • Family Planning: Provides genetic counseling information for affected families
  • Proactive Monitoring: Facilitates early intervention for at-risk family members
  • Differential Diagnosis: Distinguishes between various hypomagnesemia subtypes
  • Therapeutic Guidance: Informs medication choices and dietary modifications

Understanding Your Test Results

Our comprehensive genetic report provides clear interpretation of your results:

  • Positive Result: Identifies pathogenic FXYD2 mutations confirming hypomagnesemia type 2 diagnosis
  • Negative Result: No FXYD2 mutations detected, suggesting alternative causes for symptoms
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Determines inheritance patterns for family planning purposes

All results include detailed clinical correlations and recommendations for follow-up care with your healthcare provider.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Turnaround Time: 3 to 4 Weeks
Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York City, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session for pedigree analysis
  • Family history assessment for hypomagnesemia patterns
  • Current magnesium and electrolyte laboratory values
  • Documentation of previous treatment responses

Take Control of Your Health Today

Don’t let unexplained symptoms compromise your quality of life. Our FXYD2 Gene Hypomagnesemia Type 2 NGS Genetic DNA Test provides the clarity needed for effective management of magnesium metabolism disorders. With our discounted price of $500 USD and nationwide availability, comprehensive genetic testing has never been more accessible.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward personalized healthcare solutions.